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Abstract 
 
A NOVEL MUTAGENIC SCREEN REVEALS A MODEL FOR INTERACTION 
BETWEEN THE BIOFILM REGULATORY PROTEINS NSPS AND MBAA IN VIBRIO 
CHOLERAE 
 
Erin Campbell Young 
B.S., University of North Carolina at Chapel Hill 
M.S., Appalachian State University 
 
Chairperson:  Dr. Ece Karatan 
 
 
The regulation of the transition between a motile, planktonic state and biofilm-
associated, sessile state is important to the lifecycle of the human pathogen Vibrio cholerae, 
which is responsible for the disease cholera.  Certain environmental signals have been shown 
to affect the formation of biofilms for this bacterium.  For example, polyamines are 
ubiquitous, organic molecules that play a role in the regulation of V. cholerae biofilm 
formation.  V. cholerae detects the presence of these molecules and modifies its behavior 
through a putative signaling pathway composed of a periplasmic protein, NspS, and a 
transmembrane protein, MbaA, which has tandem cytoplasmic GGDEF and EAL domains.  
Previous studies have determined that the EAL domain of MbaA has phosphodiesterase 
activity and can break down the secondary messenger c-di-GMP, which is a positive 
regulator of biofilm formation.  In this signal transduction pathway, NspS is hypothesized to 
interact with the periplasmic domain of MbaA to inhibit the phosphodiesterase activity of the 
cytoplasmic EAL domain.  When NspS is bound by a polyamine, this alters the effect NspS 
has on the phosphodiesterase activity of MbaA either by enhancing or repressing the 
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inhibition dependent of the polyamine that is bound.  Altering the phosphodiesterase activity 
of MbaA is thought to modify levels of c-di-GMP, affecting biofilm formation.  The purpose 
of this study was to determine the potential binding surface on NspS that interacts with the 
periplasmic domain of MbaA.  Utilizing a random mutagenesis approach and screening for 
mutant clones of interest, I identified 13 amino acids of NspS thought to be important to this 
interaction.  A homology model of NspS was used to determine the location of the 13 
residues allowing me to identify the region of NspS involved in the interaction with the 
periplasmic domain of MbaA.  Based on the results of this study, I present a model of this 
periplasmic interaction in which NspS interacts with the periplasmic domain of MbaA to 
alter its phosphodiesterase activity and regulate biofilm formation in response to polyamines 
in the environment.     
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Introduction 
 
The human intestinal disease cholera affects millions of people worldwide and is 
responsible for thousands of deaths per year (1).  The causative agent for cholera is the 
Gram-negative bacterium Vibrio cholerae, which resides as a natural inhabitant of many 
aquatic ecosystems including lakes, rivers, and oceans (2, 3).  This bacterium can exist in two 
distinct states: a planktonic, free-swimming state or a sessile state that is associated with 
biofilm formation (4-6).  The planktonic state is a highly motile state in which a flagellum is 
used for propulsion and virulence-related genes are highly expressed (7).  The two main 
virulence factors of V. cholerae are toxin co-regulated pilus (TCP) and cholera toxin (CT) 
(8).  TCP is a pilus that is required for the colonization of the small intestine and cholera 
toxin is an AB5-subunit toxin in the ADP-ribosyltransferase family that is responsible for 
profuse watery diarrhea (8-10). In contrast to the motile, planktonic state, biofilms are 
aggregations or communities of cells surrounded by a matrix composed primarily of an 
extracellular polymeric substance (EPS) and can be found anchored to surfaces (11).  The 
biofilm state provides a survival advantage to bacteria especially in harsh environments by 
providing increased resistance to antibiotics as well as protection against acidic pH and UV 
exposure (12-14).  The proposed lifecycle for V. cholerae predicts that it exists primarily as a 
biofilm in aquatic environments, is ingested in part as a biofilm by humans to increase 
survival through the acidic conditions of the stomach, and then disperses from the biofilm 
once it reaches the small intestine to express virulence factors and cause disease (13, 15, 16). 
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This indicates the importance of regulating the transition between the planktonic and biofilm 
state for the lifecycle of this bacterium (13, 17).     
The transition between these two states is regulated at the molecular level by the 
secondary messenger bis-(3’-5’) cyclic dimeric guanosine monophosphate or c-di-GMP (18).  
C-di-GMP transcriptionally regulates the expression of genes encoding the proteins 
necessary for the synthesis of Vibrio polysaccharide and the other components that are 
crucial for construction of the biofilm matrix (18).  Proteins with diguanylate cyclase (DGC) 
activity typically characterized by a GGDEF domain synthesize c-di-GMP from two 
molecules of GTP (19).  Proteins with phosphodiesterase activity (PDE) break down c-di-
GMP into either 5’ pGpG or 2 molecules of guanosine monophosphate (GMP) (19).  These 
proteins are typically characterized by either an EAL or HD-GYP domain (19).  Each of 
these three c-di-GMP metabolic domains is named for the conserved amino acids important 
to its enzymatic function.  Much of the current understanding about the regulation of biofilm 
formation involves the modulation of intracellular levels of c-di-GMP as it has been well 
established that high levels of c-di-GMP lead to increased biofilm formation, whereas low 
levels lead to a motile, planktonic lifestyle for V. cholerae (18-21).    
Proteins that have GGDEF, EAL and/or HD-GYP domains tend to be a part of a 
larger protein that also contains sensory domains, likely to regulate the activity of these 
enzymatic domains based on signals received from the environment (11).  One specific 
environmental signal regulating V. cholerae biofilm formation is polyamines.  These 
molecules are aliphatic chains composed of two or more amine groups and positively 
charged at physiological pH that are synthesized by most organisms and are important for 
growth and cellular processes for most organisms (22, 23).  The polyamines norspermidine, 
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spermidine, and spermine affect biofilm formation in V. cholerae; specifically, 
norspermidine enhances biofilm formation whereas spermidine and spermine inhibit it (24-
27).  Norspermidine is less prevalent than other polyamines and has been found in many 
species of Vibrionaceae and thermophilic bacteria as well as in eukaryotic algae, white 
shrimp, and arthropods (28-32).  Spermidine and spermine are two of the most abundant 
polyamines present in the human intestine mostly due to dietary contributions or synthesis by 
intestinal cells; however, presence of the gut microbiota also adds to the level of spermidine 
found in the human intestine (33-35). The locations of these different polyamines and their 
effects on biofilm formation suggest a model in which V. cholerae can differentiate between 
the natural aquatic environment and the human intestine based on the presence of specific 
polyamines.     
Polyamines that affect biofilm formation are processed by V. cholerae through a 
pathway composed of NspS, a periplasmic protein, and MbaA, a transmembrane protein with 
tandem cytoplasmic GGDEF and EAL domains (24-27).  Previous studies have shown that 
NspS binds the polyamines norspermidine, spermidine, and spermine and the deletion of 
either nspS or mbaA abrogates the effects of polyamines on biofilm formation (24-27).  
Further, the EAL domain of MbaA has been characterized to have phosphodiesterase activity 
resulting in the breakdown of c-di-GMP (26, 36).  The deletion of mbaA results in enhanced 
biofilm formation whereas the deletion of nspS results in an inhibition of biofilm formation, 
which suggests that NspS inhibits the PDE activity of MbaA (24).  Thus, the current model 
for this signaling pathway is that NspS interacts with the periplasmic domain of MbaA to 
inhibit its PDE activity leading to an increase in c-di-GMP and an increase in biofilm 
formation (Figure 1) (24, 26).  When NspS binds norspermidine, there is a greater inhibition 
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of the PDE activity of MbaA leading to enhanced biofilm formation presumably through 
increased levels of c-di-GMP (24, 26).  In contrast, when NspS binds spermidine or 
spermine, the PDE activity is no longer inhibited resulting in the breakdown of c-di-GMP 
and a decrease in biofilm formation (25-27).   
 
 
Fig 1. Model of NspS-MbaA signaling pathway. (a) Intermediate state of interaction in 
which NspS interacts with the periplasmic domain of MbaA to inhibit the PDE activity of 
MbaA and an intermediate amount of biofilm formation occurs. (b) When NspS is bound by 
norspermidine, there is a greater inhibition of the PDE activity of MbaA leading to higher 
levels of c-di-GMP and increased biofilm formation. (c) When NspS is bound by spermine 
(or spermidine), the inhibition of the PDE activity of MbaA is relieved resulting in c-di-GMP 
being broken down into pGpG and a decrease in biofilm formation.  Black triangles represent 
c-di-GMP and black circles represent pGpG. The shorter zigzag line in (b) represents 
norspermidine and the longer zigzag line in (c) represents spermine.  Adapted from (26, 27).                 
 
The aim of this study was to investigate the putative interaction between NspS and 
MbaA by identifying the amino acids of NspS important to the interaction with the 
periplasmic domain of MbaA.  Through the introduction of random mutations into the nspS 
gene and subsequent screening, I identified the region of NspS thought to interact with the 
periplasmic domain of MbaA.  Using the information determined from this study, I 
developed a working model of the periplasmic interaction between these two biofilm 
regulatory proteins.    
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Methods 
Bacterial Strains and Growth Conditions 
The strains in this study were derived from Vibrio cholerae O139 MO10.  The 
bacterial strains and plasmids used in this study are listed in Table 1.  V. cholerae strains 
were grown at 27°C and E. coli strains were grown at 37°C.  All strains were grown in Luria-
Bertani (LB) broth.  Where appropriate, streptomycin was used at 100 μg mL-1; tetracycline 
was used at 10 μg mL-1 for E. coli strains and at 2.5 μg mL-1 for V. cholerae strains.  Primers 
were synthesized by Eurofins MWG Operon or Sigma and DNA sequencing was performed 
by Eurofins MWG Operon.               
 
Table 1. Bacterial strains and plasmids.  
Strain/Plasmid Genotype Source 
Plasmids   
pACYC184 Cloning plasmid, TetR, CmR New England 
Biolabs 
pNP1 pACYC184::nspS-V5 (27) 
E. coli strains   
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 
recA1 endA1 hsdR17 (rK–, mK+) phoA 
supE44 λ– thi-1 gyrA96 relA1 
Invitrogen 
AK006 DH5α with pACYC184 (37) 
AK014 DH5α with pNP1 (37) 
V. cholerae strains   
PW249 MO10, clinical isolate of V. cholerae O139 
from India, SmR 
(38) 
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Table 1. (continued)  
Strain/Plasmid Genotype Source 
V. cholerae strains   
PW514 MO10 lacZ::vpsLp→lacZ, ΔnspS, SmR (24) 
AK007 PW514 with pACYC184 (27) 
AK831 PW514 with pNP1 (37) 
AK944 PW514 with pACYC184::nspS-V5R219S This study 
AK945 PW514 with pACYC184::nspS-V5S216I This study 
AK946 PW514 with pACYC184::nspS-V5S216R This study 
AK947 PW514 with pACYC184::nspS-V5N268D This study 
AK948 PW514 with pACYC184::nspS-V5S216N This study 
AK949 PW514 with pACYC184::nspS-V5R219H This study 
AK950 PW514 with pACYC184::nspS-V5F243V This study 
AK951 PW514 with pACYC184::nspS-V5D263V This study 
AK952 PW514 with pACYC184::nspS-V5V218L This study 
AK953 PW514 with pACYC184::nspS-V5S79C This study 
AK954 PW514 with pACYC184::nspS-V5L40H This study 
AK955 PW514 with pACYC184::nspS-V5L89W This study 
AK956 PW514 with pACYC184::nspS-V5L82R This study 
AK957 PW514 with pACYC184::nspS-V5L82P This study 
AK958 PW514 with pACYC184::nspS-V5S79G This study 
AK959 PW514 with pACYC184::nspS-V5R219C This study 
AK960 PW514 with pACYC184::nspS-V5N268S This study 
AK961 PW514 with pACYC184::nspS-V5L40R This study 
AK962 PW514 with pACYC184::nspS-V5F66V This study 
AK963 PW514 with pACYC184::nspS-V5F84V This study 
AK964 PW514 with pACYC184::nspS-V5D43N This study 
AK965 PW514 with pACYC184::nspS-V5V218A This study 
AK966 PW514 with pACYC184::nspS-V5L40P This study 
AK967 PW514 with pACYC184::nspS-V5F66Y This study 
 
 
7 
 
Error Prone PCR 
Error prone PCR was performed on purified pNP1 plasmid using the GeneMorph II 
random mutagenesis kit (Agilent Technologies).  Following manufacturer’s instructions, 1 μg 
of target DNA was amplified for 30 cycles to achieve an approximate mutational frequency 
of 0-4.5 mutation(s) per kilobase.  The cycling conditions were as follows: initial 
denaturation at 95°C for 2 minutes, 30 cycles of denaturation at 95°C for 30 seconds, 
annealing at 53°C for 30 seconds, and extension at 72°C for 1.5 minutes, and a final 
extension at 72°C for 10 minutes. 
 
nspS Mutant Library Generation 
Gel purified products from the error prone PCR reaction and purified pACYC184 
plasmid were digested with restriction enzymes NcoI and EcoRI.  The PCR products were 
ligated into pACYC184 using ElectroLigase following manufacturer’s recommendations 
(New England Biolabs).  After ligation, the plasmid products were transformed into E. coli 
DH5α.  Successful transformation was confirmed by PCR and sequencing using the forward 
primer P291 (5’ GCATGATGAACCTGAATCGC), which anneals upstream of the NcoI 
digest site used for cloning into pACYC184, and the reverse primer P292 (5’ 
GCCTTTATTCACATTCTTGCC), which anneals downstream of the EcoRI digest site used 
for cloning into pACYC184.  To generate the final mutant library, the ligated 
pACYC184::mutant-nspS-V5 plasmid was transformed again into DH5α.  One mL LB was 
added to each agar plate on which there was growth post-transformation and the colonies 
were scraped using a plate spreader so they were resuspended into the LB.  The LB from 
each plate was combined and a midi prep was performed with a Wizard Plus Midiprep DNA 
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purification kit (Promega) to purify the plasmids. This process was repeated a second time to 
generate the final nspS mutant library.    
 
Screening for Biofilm-deficient Mutants 
Following transformation of the final nspS mutant library into a ΔnspS strain of V. 
cholerae, individual colonies were inoculated in LB with appropriate antibiotics into separate 
wells of a 2 mL 96-well plate and grown overnight shaking at 27°C.  The following day, the 
overnight culture was diluted 1:50 in fresh media in new wells of 2-mL 96-well plate shaking 
at 27°C until the bacteria reached mid-log phase.  Each well was diluted to an OD655 of 0.04 
in 125 μl in 96-well microtiter plates and these plates were grown statically at 27°C for 
approximately 24 hours. They were then assessed for biofilm formation using a modified 
version of the crystal violet biofilm staining protocol described previously (39).  Briefly, 
planktonic cells were removed and the remaining biofilm washed with 1X phosphate 
buffered saline (PBS).  A 1% crystal violet solution was used to stain the biofilm for 25 
minutes.  After removal of the stain, two consecutive 1X PBS wash steps were performed.  
The microtiter plates were dried and the crystal violet was solubilized in 135 μl of 95% 
ethanol for approximately 10 minutes.  The absorbance of 125 μl from each well was 
analyzed at a wavelength of 595 nm.  After the initial transformation of the nspS mutant 
library, biofilm formation was analyzed in triplicate for one biological replicate of each 
mutant clone.  Based on these results, mutant clones that were different from the positive 
control, V. cholerae ΔnspS with pACYC184::nspS, were analyzed again for biofilm 
formation using the same protocol described above.  For the second biofilm assay using 
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crystal violet staining, three biological replicates were assessed in triplicate for each “down” 
mutant clone to confirm the low biofilm phenotype seen in the initial screen.             
 
Western Blot Analysis 
 Following overnight growth at 27°C shaking, cells were pelleted by centrifugation, 
resuspended in 250-300 μl 1X PBS, sonicated 3 times for 10 seconds each, and centrifuged at 
16,000 x g for 20 minutes at 4°C.  The supernatant was combined with Laemmli sample 
buffer containing β-mercaptoethanol in a 1:1 ratio and incubated at 65°C for 5 minutes.  Each 
sample was run on a polyacrylamide gel for between 1 to 1.5 hours at 240 V.  The gel was 
transferred onto a PVDF membrane using a BIO-RAD Mini Trans Blot for between 45-70 
minutes.  After the transfer, the membrane was blocked for either 1 hour at room temperature 
or 4 hours at 4°C in 5% (w/v) non-fat dry milk in 1X PBS-T (0.05% (v/v) Tween 20 solution 
in 1X PBS) after which it was washed 3 times for 5 minutes with 1X PBS-T.  The membrane 
was then incubated for 1 hour at room temperature with mouse monoclonal anti-V5 Tag 
antibody conjugated with Horseradish Peroxidase (HRP) (BIO-RAD) diluted 1:5000 and a 
Precision Protein StrepTactin-HRP Conjugate antibody (BIO-RAD) diluted 1:10,000.  The 
anti-V5 antibody was utilized to react with the V5 tag that was engineered into the nspS 
sequence when it was cloned into pACYC184.    The membrane was washed 3 times for 5 
minutes with 1X PBS-T and was then incubated with SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific) for 5 minutes.  The membrane was imaged 
with a BIO-RAD Molecular Imager Gel Doc XR System.     
 
 
10 
 
Biofilm Assay  
Overnight cultures were diluted 1:50 into 2 mL new LB media with antibiotics and 
grown to mid-log phase shaking at 27°C. Strains were diluted to an OD655 of 0.04 in 0.3 mL 
LB with antibiotics in borosilicate test tubes in the absence or presence of norspermidine. 
These tubes were incubated statically at 27°C for 24 hours. After incubation, planktonic cells 
were removed and the remaining biofilm was washed with 0.3 mL 1X PBS. The biofilm was 
homogenized by vortexing for 30 seconds with 1.0 mm glass beads (BioSpec) in 0.3 mL 1X 
PBS. The cell density of the homogenized biofilm was measured at OD655 using an iMark 
Microplate Reader (BIO-RAD). All experiments were performed in triplicate and repeated 
for reproducibility.   
 
Sequencing and Analysis         
Plasmids were isolated from mutant clones of interest and sent for sequencing using 
the forward primer P291 and the reverse primer P292.  Primers P37  
(5’ CGTTTTGGCTAACGTCTCCGCG) and P39 (5’ GGTATGCTTAAAGCCAGTGTCG) 
were utilized when necessary for additional sequencing.  These primers anneal to nucleotides 
261-282 and nucleotides 496-517 of the nspS gene respectively.  The sequencing results were 
analyzed using Vector NTI (Thermo Scientific).  A contig was generated for each sequenced 
mutant clone and was translated into a protein sequence for alignment against the wild type 
NspS protein sequence to determine changes in amino acids.  
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Bioinformatics  
 
The intensive mode of the Phyre2 web portal for protein modeling, prediction, and 
analysis (http://www.sbg.bio.ic.ac.uk/servers/phyre2/html/page.cgi?id=index) was used to 
generate a homology model of the NspS protein using an input of six different proteins as 
templates: PotF, a putrescine receptor in E. coli; PotD, a spermidine and putrescine binding 
protein in Streptococcus pneumoniae; SpuD and SpuE, polyamine binding proteins in 
Pseudomonas aeruginosa; an unnamed putative spermidine and putrescine ABC transporter 
in Listeria monocytogenes, and PotD spermidine and putrescine binding protein in E. coli 
(40).  The UCSF ChimeraX molecular visualization program was utilized to manipulate and 
generate images of the NspS homology model (41).  A CLUSTALW multiple sequence 
alignment was performed for NspS and five identified homologs from other bacterial species 
(26, 42, 43).  These five NspS-like proteins are Ping_1238 from Psychromonas ingrahamii 
(NCBI Accession number: WP_011769631), HCH_06688 from Hahella chejuensis (NCBI 
Accession number: WP_011400370), Ssed_2394 from Shewanella sediminis (NCBI 
Accession number: WP_012142738), PST_0371 from Pseudomonas stutzeri (NCBI 
Accession number: WP_011911609) and SMc_00991 from Sinorhizobium meliloti (NCBI 
Accession number: NP_384966).    The output from this alignment was visualized and a final 
image generated with ESPript 3.0 (44). 
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Results 
 
Construction of a nspS Mutant Library 
 
To introduce random mutations, the wild type nspS gene was subjected to error prone 
PCR.  Following purification, the error prone PCR products were cloned into the plasmid 
pACYC184 and transformed into DH5α E. coli cells.  Based on a small subset of mutant 
clones that were sequenced, the mutation rate was determined to be approximately 50% and 
the missense mutation rate was estimated to be approximately 30% (data not shown).  This 
confirmed the success of the error prone PCR.  Two subsequent rounds of transformation of 
pACYC184::mutant-nspS-V5 into DH5α yielded a final mutant library size estimated by 
colony count to be composed of approximately 20,000 mutant clones.  
 
Screening of mutant clones for low biofilm formation and NspS protein expression 
 
Following the successful construction of the final nspS mutant library, the 
development of a screening process to identify mutant clones of interest was necessary.  A 
nspS deletion strain of V. cholerae forms a low amount of biofilm (24) presumably because 
NspS can’t interact with the periplasmic domain of MbaA to inhibit the phosphodiesterase 
activity of the EAL domain.  Based on this premise, mutations in the amino acids of NspS 
important to the interaction with the periplasmic domain of MbaA should also result in 
strains with low biofilm formation.  Thus, a high-throughput screening method (Figure 2) 
was developed in which crystal violet staining was utilized to assess the amount of biofilm 
formation for mutant clones in the nspS mutant library.  
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Fig 2. Mutant Clone Screening Process. (a) The nspS mutant library was transformed into V. 
cholerae ∆nspS strain and colonies were individually grown in separate wells of a 96-well 
deepwell plate. (b) For each mutant clone, crystal violet staining was performed to assess 
biofilm formation for one biological replicate. (c) Biofilm formation using crystal violet stain 
was used again to assess three biological replicates for mutant clones with low biofilm 
formation in the initial assay. (d) Mutant clones that produced low biofilms were analyzed 
via western blot for protein expression. (e) For clones that had protein expression, a final 
biofilm assay was performed that measured the cellular density of the biofilm to confirm the 
low biofilm phenotype. (f) Any mutant clones that had low biofilm formation and protein 
expression that was detected via western blot were purified and sent for sequencing and 
analysis.   
 
After transformation of the nspS mutant library into a V. cholerae ΔnspS strain, 
biofilm formation was analyzed in triplicate for one biological replicate of each mutant clone.  
In total, 1,441 mutant clones were screened for biofilm formation with this initial crystal 
violet staining biofilm assay.  As expected, there was a large amount of variation in biofilm 
formation between different mutant clones during this initial assay as seen in an example 
biofilm graph of 96 mutant clones in Figure 3.  Based on these results, only mutant clones 
that were different from the positive control, V. cholerae ΔnspS with pACYC184::nspS, were 
analyzed again for biofilm formation.  For the second biofilm assay using crystal violet 
staining, three biological replicates were assessed in triplicate each for each “down” mutant 
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clone to confirm the low biofilm phenotype seen in the initial screen.  Of the 1,441 mutant 
clones screened, 338 were determined to be “down” mutant clones due to low biofilm 
formation and were analyzed again with a second assay for biofilm formation using crystal 
violet staining.              
 
 
 
Fig 3. Initial biofilm analysis for a set of 96 mutant clones.  Crystal violet staining was used 
to analyze biofilm formation for each mutant clone.  The positive control is V. cholerae 
ΔnspS with pACYC184::nspS-V5 and the negative control is V. cholerae ΔnspS with 
pACYC184.  The error bars represent standard deviations of three technical replicates.   
 
 
After the second step in the screening process, the 293 mutant clones confirmed to 
have a low biofilm phenotype were analyzed for NspS protein expression.  This was 
accomplished with western blots by probing with a monoclonal anti-V5 tag antibody that 
recognized the V5 tag engineered to the C-terminus of NspS.  Mutant clones showing protein 
expression at the correct size as the positive control, approximately 40 kDa, were continued 
forward in the screening process.  Of the 293 mutant clones analyzed, there were 106 that 
had V5 expression indicating the presence of the NspS protein.  In an example western blot 
of seven mutant clones (Figure 4a), only mutnspS_426, mutnspS_456, mutnspS_486 and 
mutnspS_487 showed NspS protein expression and were continued forward in the process for 
further analysis. Any mutant clones for which protein expression could not be detected on a        
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Fig 4. Analysis of NspS protein expression and tertiary screen of biofilm formation.  (a) 
Western blot analysis with a ladder in Lane 1 and positive and negative controls respectively 
in Lanes 2 and 3.  The positive control is V. cholerae ΔnspS with pACYC184::nspS-V5 and 
the negative control is V. cholerae ΔnspS with pACYC184.  Lanes 4-10, seven mutant clones 
identified from two crystal violet biofilm assays as having low biofilm formation. This image 
was taken with a BIO-RAD Molecular Imager Gel Doc XR System and manually exposed 
for two minutes. (b) Graph of biofilm formation for the four mutant clones from (a) that 
showed NspS protein expression.  Three biological replicates were analyzed in triplicate per 
mutant clone for biofilm formation.  The positive and negative controls are the same as in (a).  
Error bars show standard deviations of three biological replicates.  
                  
 
western blot were assumed to either have mutations that prevented proper folding and 
therefore did not result in stable protein or had mutations that resulted in truncated proteins 
through the introduction of premature stop codons.  In either case, these mutants were not of 
interest to the study and were not investigated further.   
The last step in the screening process was a final assessment of mutant clone biofilm 
formation using a different method than crystal violet staining to confirm the low biofilm 
phenotype. Mutant clones that showed NspS expression were analyzed for biofilm formation 
by homogenizing the biofilm with glass beads and measuring the cell density.  Figure 4b is 
an example graph of this assessment showing the cell density of the biofilms for the four 
mutant clones in Figure 4a that had NspS protein expression as well as the biofilm cell 
density of the positive and negative controls for comparison.  All of the 106 mutant clones 
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that showed NspS protein expression were assessed for biofilm formation for a third time.  
Ninety-eight mutant clones still showed a low amount of biofilm formation in this final 
assay.  Plasmids were isolated from these mutant clones and the sequence of the cloned nspS 
gene was determined.            
 
Amino acids identified in the mutant clone screen 
  
Of the 1,441 mutant clones initially screened, 73 mutant clones were successfully 
sequenced and changes from the wild-type NspS sequence were determined (Table 2a-c).  
There were 43 clones with one missense mutation, 24 with two, five with three and one with 
four missense mutations.        
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Table 2. Mutations identified in sequenced mutant clones.  (a) Mutant clones with single 
missense mutations (b) Mutant clones with double missense mutations (c) Mutant clones 
with either three or four missense mutations.  All mutations are listed as the wild type amino 
acid, the position of the amino acid followed by the amino acid mutation determined from 
sequencing.            
 
 
 
The single missense mutations were given the focus of investigation for the remainder 
of this study as more than one mutation presents the difficulty of having to parse out the 
effects of each individual mutation.  Of the 43 single missense mutations that were identified 
by the screen, there were only 19 unique amino acids of NspS affected.  Thirteen of these 
occurred in more than one mutant clone providing additional support that these amino acids 
could be important to the interaction between NspS and the periplasmic domain of MbaA.  
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For some of these 13 amino acids, the mutation was the same change (i.e. phenylalanine at 
position 243 was mutated twice, both times to a valine); however, in other cases, there were 
multiple different changes that occurred.  This was true for the arginine at position 219, 
which was mutated to a cysteine, a histidine, and a serine in different mutant clones.  
Interestingly, some of the amino acids that occurred as single mutations also appeared as one 
of the mutations in clones with double missense mutations. In particular, asparagine 68, 
serine 79, serine 216, arginine 219, and aspartic acid 263 all occurred more than once in a 
clone with a double missense mutation.  The frequency at which these residues were 
identified by the screening process suggested that further investigation into the effects of 
these mutations was warranted.    
 
Norspermidine addition had a varying effect on NspS mutant clone biofilm formation  
 
Previous work has demonstrated that NspS binds the polyamines spermine, 
spermidine, and norspermidine (24, 26, 27).  Spermine and spermidine inhibit biofilm 
formation in V. cholerae.  Since the mutant clones of interest have already been shown to 
form low biofilms, it would be very difficult to detect a response to either one of these 
polyamines.  In contrast, norspermidine enhances biofilm formation presumably through the 
function of NspS as deletion of nspS abrogates the effect of norspermidine (24).  To test the 
effect of norspermidine on the single mutations of NspS identified by the screen, biofilm 
formation for each mutant clone was analyzed in the absence of and presence of 100 μM 
exogenous norspermidine (Figure 5).  
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Fig 5. Effects on biofilm formation of single missense NspS mutant clones with or without 
exogenous norspermidine.  The experiments were performed in triplicate and the error bars 
show the standard deviation of three biological replicates. Each mutant clone is listed only by 
the single missense mutation present in that strain of V. cholerae ΔnspS pACYC184::nspS-
V5. The positive control is V. cholerae ΔnspS pACYC184::nspS-V5 and the negative control 
is V. cholerae ΔnspS pACYC184.  A t-test was used to compare biofilm formation between 
LB only and LB + 100 μM nspd for each individual mutant clone analyzed.  A star indicates 
a statistically significant difference in biofilm formation with and without the addition of 
norspermidine. A p-value of <0.05 was considered significant.   
 
 
In response to the addition of norspermidine, some of the mutant clones were 
unresponsive, some were desensitized, and some responded with biofilm formation that was 
similar to that of the positive control (Table 3).  About half of the mutant clones analyzed did 
have a statistically significant increase in biofilm formation when exogenous norspermidine 
was added to the LB.  Those mutant clones that did have an increase in biofilm formation 
were denoted as either desensitized or responsive to the norspermidine based on the amount 
of biofilm formation.  The mutant clones that did not have a significant increase in biofilm 
formation were considered to be unresponsive.  Interestingly, mutant clones with a mutation 
in the serine 216 were unresponsive to norspermidine addition regardless of the type of the 
amino acid change.  This was not the case for other mutant clones such as arginine 219, 
which showed a significant increase in biofilm formation in the presence of 100 μM when 
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changed to a histidine, but not when changed to a cysteine or serine.  These results might 
provide insight into amino acids that may contribute to the mechanism by which NspS binds 
norspermidine.     
Table 3. Categorization of mutant clone response to exogenous norspermidine.  Each mutant 
clone is listed only by the single missense mutation present in that strain of V. cholerae 
ΔnspS pACYC184::nspS-V5. 
 
 
 
 
Mutations identified in the screening process cluster in two distinct locations on NspS 
 
Previous research has demonstrated that even though NspS can bind polyamines, it 
does not play a role in transport (26); however, the closest homologs to NspS whose 
structures have been determined are polyamine transport proteins.  To determine the location 
of the mutated amino acids identified by the screening process, six of these proteins were 
used as templates to construct a NspS homology model using Phyre2 (40).  Using the 
ChimeraX program (41), a ribbon model diagram was generated and the 13 amino acids that 
occurred in more than one missense mutation mutant clone were highlighted with a pink 
color and space fill option (Figures 6a and 6b).  The amino acids were determined to be in 
two main groups or locations on the homology model (Figure 6b).  Further analysis of the 
homology model revealed that the highlighted amino acids appeared as though they might be 
on or close to the surface of NspS.               
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Fig 6. NpsS homology model. (a) Ribbon-diagram model of NspS with a side view of the 
protein.  (b) Same as (a) but view has been rotated to look at a “center” view into the mouth 
of the protein. (c) Same as (b) but with the surface filled in/added to the homology model. (d) 
Same as (c) but rotated down to demonstrate a different view/angle of NspS. 
 
In order to investigate this possibility, the surface of the protein was added to the 
homology model.  The pink color of several of the highlighted amino acids was apparent 
when viewing the homology model (Figure 6c).  This indicates that these amino acids are 
likely on the surface of NspS, which may provide one continuous surface or multiple points 
of interaction with the periplasmic domain of MbaA.  To examine the possibility of how the 
point(s) of interaction may interact with MbaA, the homology model was adjusted to 
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different angles.  One specific view (Figure 6d) revealed a groove that could provide a 
surface of interaction with another protein.  The location of the mutated amino acids 
identified in the screening process provided further support for this hypothesis.     
 
Conserved amino acids of NspS were identified from protein alignment 
 
Previous work has identified other NspS/MbaA pairs of proteins present in other 
Proteobacteria (26).  Five NspS-like proteins with predicted polyamine ligands were utilized 
to generate a protein alignment against NspS to determine conserved amino acids (Figure 7).  
The alignment showed that 22 different amino acid positions were conserved across all six 
proteins.  There were also many other cases in which positions had a consensus residue, 
meaning that greater than 50% of the proteins had the same amino acid at that position.  
Further, a short sequence of amino acids from approximately position 126 to position 144 
was identified that appeared to be the most well conserved area among these six proteins.  
Interestingly, the only mutation in this 18-residue stretch that occurred in the screening 
process was a mutant clone with a double missense mutation in which one of the mutations 
was a change from histidine at position 126 to tyrosine.  As seen in the alignment, NspS has a 
histidine at that position, whereas four of the homologs have a tyrosine indicating that this 
mutation may not have a significant impact on the structure of NspS.  The lack of mutations 
identified in this area of the NspS protein may suggest that the conservation seen in this 18-
bp amino acid stretch may be so integral to its protein structure that those residues cannot be 
altered without a detrimental effect on its structure. 
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Fig 7. Protein alignment comparing NspS sequence to five NspS-like proteins identified in 
other bacterial species.  Each protein in this alignment has one or more polyamines as its 
predicted ligand.  Clustal W alignment software was used to compare these six proteins and 
the final image was generated using ESPript 3.0 (42-44). The positions in the alignment 
highlighted in black indicate one identical amino acid across all six proteins. The positions 
highlighted in gray indicate some similarity across the six proteins and is indicated in 
boldface font. Numbered positions are based on the NspS protein sequence.             
 
 
When the 13 amino acids that were mutated in more than one mutant clone were 
examined on the protein alignment, there was only one conserved across all six proteins, the 
aspartic acid at position 263.  In another case, the aspartic acid at position 43 of NspS was 
also mutated in multiple mutant clones.  The protein alignment in Figure 7 shows that three 
of the NspS-like proteins have an aspartic acid at this position while the other two have a 
glutamic acid.  This indicates the conservation of an amino acid with a negatively charged 
side chain at this position for these proteins.  At position 66, half of the proteins, including 
NspS, have a phenylalanine and the other half have a tyrosine.  This indicates the importance 
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of a non-polar aromatic amino acid at this position for these proteins.  There are several 
amino acids of the 13 that do not have similarity across these six proteins; however, some of 
them are located near well conserved amino acids.  For example, both leucine 40 and aspartic 
acid 43 are in close in proximity to the tryptophan conserved across all six proteins at 
position 41.  Also, serine 79, leucine 82, phenylalanine 84, and leucine 89 are all clustered 
near an aspartic acid residue at position 85 that is identical for all six proteins.  This suggests 
the possibility that amino acids 41 and 85 could be important to the interaction between NspS 
and the periplasmic domain of MbaA.  While our screening process did not show mutations 
in these specific residues, it remains possible that mutations in residues in close proximity 
disrupted the binding interface of NspS to affect interaction.        
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Discussion 
Vibrio cholerae biofilm formation is regulated by specific polyamines in the 
environment including spermine, spermidine, and norspermidine.  Based on previous 
research, the proposed model for the signal transduction of polyamines occurs through a 
pathway composed of NspS, a periplasmic binding protein, and MbaA, a transmembrane 
protein with tandem cytoplasmic GGDEF and EAL domains (24-27).  The interaction of 
NspS with the periplasmic domain of MbaA is proposed to alter the phophodiesterase 
activity of the EAL domain of MbaA, which presumably affects the intracellular level of the 
secondary messenger c-di-GMP.  This study aimed to identify the amino acids of NspS 
important to the interaction with the periplasmic domain of MbaA to elucidate more 
information about the mechanism of this signal transduction.  
In this study, we utilized a mutagenic screen to identify amino acids of NspS 
important to the interaction with the periplasmic domain of MbaA. This screening process 
yielded 13 amino acids thought to be involved in this interaction.  Analysis of biofilm 
formation of the mutant clones identified in this study after the addition of norspermidine 
confirmed a role for these residues in the signal transduction of norspermidine.  Certain 
mutations abrogated the effect of norspermidine indicating that without a specific amino acid 
in certain positions, NspS cannot interact properly with the periplasmic domain of MbaA to 
inactivate its phosphodiesterase activity.  Interestingly, other identified amino acids did not 
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appear to have the same effect indicating that they may only play a contributory role or the 
change in amino acid was not significant enough from the wild type to affect the interaction.  
Locating the 13 amino acids on the NspS homology model led to the hypothesis that 
these amino acids could either form one continuous surface of interaction or two distinct 
points of contact with the periplasmic domain of MbaA.  The homology model was rotated to 
an angle that presented a groove for binding to another protein (Figure 8a).  Combined with 
the location of the amino acids and the presence of a groove, this suggests that NspS sits on 
top of the periplasmic domain of MbaA relative to the inner membrane (Figure 8b).  The 
predicted pocket for polyamine binding is unobstructed in this orientation and could provide 
the mechanism by which conformation changes occur that are then relayed to the 
cytoplasmic domains of MbaA.   
 
 
 
Fig 8. Proposed model of interaction between NspS and the periplasmic domain of MbaA. 
(a) Surface-filled Homology Model of NspS.  The pink amino acids were identified by the 
mutagenesis screen.  The orange circle highlights the predicted ligand binding pocket where 
polyamines would bind and the black arrows point to the potential point of interaction with 
the periplasmic domain of MbaA.  (b) Cartoon model of the interaction between NspS and 
MbaA relative to the inner membrane.  The orange oval on NspS represents the predicted 
ligand binding pocket where polyamines would bind.    
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Based on the NspS/MbaA signal transduction pathway model, there are three 
different states of interaction between these two proteins (26).  Low biofilm formation in 
presence of the polyamines spermine or spermidine, an intermediate amount of biofilm 
formation when no polyamines are bound by NspS, and high biofilm formation when 
norspermidine is present in the environment.  Three proposed states of interaction suggest 
that NspS and the periplasmic domain of MbaA interact constitutively and a conformational 
change occurs to alter the PDE activity of MbaA only when NspS is bound to a polyamine. 
The idea of this constitutive interaction is supported in literature by other examples of 
periplasmic binding proteins (PBPs) interacting with transmembrane proteins.  An example 
of this is the two-component system in Vibrio harveyii that responds to quorum sensing 
signals to generate bioluminescence.  In this pathway, LuxP is a PBP that constantly interacts 
with LuxQ, a sensor kinase spanning the inner membrane; however, when LuxP binds to its 
ligand, autoinducer-2, this alters the conformation of LuxQ and results in the inactivation of 
the kinase activity of its intracellular domain (45).  The data from our study supports this 
model of the pathway in which NspS and the periplasmic domain of MbaA are constitutively 
interacting and conformational changes occur when polyamines bind to NspS.  
We acknowledge that there are shortcomings in relying on a homology model of 
NspS based on the structure of other proteins.  Given the difficulties and the labor-intensive 
process involved in the crystallization of a protein, a homology model of NspS can 
nevertheless be helpful.  It was intentional that multiple template proteins were utilized rather 
than just one as a way to increase the accuracy of the NspS homology model.  However, 
moving forward, working towards solving the structure of NspS would ultimately enable 
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better study of this system.  The results from this study would be able to then be tested or 
examined on a structure known to be accurate.  Further, we have also not discounted the 
possibility that the stoichiometry of this interaction may not be 1:1 and that dimerization of 
one or both proteins may be important to this interaction.  There are other examples of 
periplasmic binding proteins in which a periplasmic protein as a monomer interacts with a 
dimer of a transmembrane protein such as a pathway in P. fluorescens that regulates biofilm 
formation in response to levels of inorganic phosphate (46).  In this case, the transmembrane 
protein LapD must dimerize to form the binding site required for the periplasmic LapG 
protein.  Further work investigating this possibility for my own signaling pathway will be 
required before a complete picture of the proposed NspS-MbaA interaction is elucidated. 
The results from this study support the hypothesis that NspS and the periplasmic domain of 
MbaA interact to transduce polyamines in the environment as well as provide a model 
depicting that interaction.  
This mechanism demonstrates a signaling paradigm in which bacterial species are 
able to differentially sense signals in the environment, transduce the information into the cell 
and modify their behavior to respond accordingly.  With the identification of multiple 
homologous NspS/MbaA pairs in other Proteobacteria (26), understanding this signaling 
system could not only elucidate information about how V. cholerae interacts with its 
environment but also how other bacterial species do as well.          
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Figure S1. Analysis of NspS protein expression and tertiary screen of biofilm formation for 
mutant clones. (a-bl) Western blots with corresponding final biofilm formation analysis for the 
mutant clones that showed low biofilm formation in the first and second screens.  For western blots 
with the exception of (i) and (s), the ladder is in Lane 1 or 2. For (i), the ladder is in Lane 10. For (s), 
the ladder did not image well enough to be seen on the western.  An arrow points to the NspS band 
in the positive control lane in each of the western blots.  All western blot images were taken with a 
BIO-RAD Molecular Imager Gel Doc XR System.  For all figures, the positive control is V. cholerae 
ΔnspS with pACYC184::nspS-V5 and the negative control is V. cholerae ΔnspS with pACYC184. 
For biofilm graphs, three biological replicates were analyzed in triplicate per mutant clone for 
biofilm formation.  Error bars show standard deviations of three biological replicates. 
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